The IκB kinase inhibitor ACHP targets the STAT3 signaling pathway in human non-small cell lung carcinoma cells

The IκB kinase inhibitor ACHP targets the STAT3 signaling pathway in human non-small cell lung carcinoma cells

10.3390/biom9120875

Saved in:

書目詳細資料
Main Authors:	Lee, J.H., Mohan, C.D., Basappa, S., Rangappa, S., Chinnathambi, A., Alahmadi, T.A., Alharbi, S.A., Kumar, A.P., Sethi, G., Ahn, K.S., Rangappa, K.S.
其他作者:	PHARMACOLOGY
格式:	Article
出版:	MDPI AG 2021
主題:	ACHP Cytotoxicity NSCLC STAT3 signaling inhibitor
在線閱讀:	https://scholarbank.nus.edu.sg/handle/10635/206248
標簽:	添加標簽沒有標簽, 成為第一個標記此記錄!

相似書籍

Brusatol, a nrf2 inhibitor targets stat3 signaling cascade in head and neck squamous cell carcinoma
由: Rangappa, K.S., et al.
出版: (2021)

Novel 1,3,4-oxadiazole targets STAT3 signaling to induce antitumor effect in lung cancer
由: Malojirao, V.H., et al.
出版: (2021)

Attenuation of STAT3 signaling cascade by daidzin can enhance the apoptotic potential of bortezomib against multiple myeloma
由: Yang, M.H., et al.
出版: (2021)

Identification of a novel 1,2 oxazine that can induce apoptosis by targeting NF-κB in hepatocellular carcinoma cells
由: Somu, C., et al.
出版: (2021)

Tris(Dibenzylideneacetone)dipalladium(0) (tris dba) abrogates tumor progression in hepatocellular carcinoma and multiple myeloma preclinical models by regulating the stat3 signaling pathway
由: Arora, Loukik, et al.
出版: (2022)

Celastrol inhibits proliferation and induces chemosensitization through down-regulation of NF-κB and STAT3 regulated gene products in multiple myeloma cells
由: Kannaiyan, R., et al.
出版: (2014)

Brusatol suppresses STAT3-driven metastasis by downregulating epithelial-mesenchymal transition in hepatocellular carcinoma
由: Lee, J.H., et al.
出版: (2021)

Role of stat3 in cell migration
由: TENG TERK SHIN
出版: (2011)

Activation of STAT3 and STAT5 signaling in epithelial ovarian cancer progression: Mechanism and therapeutic opportunity
由: Wu, C.-J., et al.
出版: (2021)

Signal transducer and activator of transcription (STATs) proteins in cancer and inflammation: Functions and therapeutic implication
由: Loh, C.-Y., et al.
出版: (2021)

Emodin inhibits growth and induces apoptosis in an orthotopic hepatocellular carcinoma model by blocking activation of STAT3
由: Subramaniam, A., et al.
出版: (2014)

Discovering novel SNPs that are correlated with patient outcome in a Singaporean cancer patient cohort treated with gemcitabine-based chemotherapy
由: Limviphuvadh, Vachiranee, et al.
出版: (2018)

Novel 1,3,4-oxadiazole induces anticancer activity by targeting NF-κB in hepatocellular carcinoma cells
由: Mohan, C.D, et al.
出版: (2020)

Anti-myeloma effects of icariin are mediated through the attenuation of JAK/STAT3-dependent signaling cascade
由: Jung Y.Y., et al.
出版: (2019)

CHARACTERIZING CISPLATIN-RESISTANT NSCLC CELLS AND IDENTIFYING TRAIL AS A POTENTIAL SECOND-LINE THERAPY IN REFRACTORY CANCER CELLS
由: SEAH BEE KEE SERENA
出版: (2013)

ROLE OF TISSUE-SPECIFIC STAT PROTEINS IN TUMOR AND AUTOIMMUNITY
由: YANG FAN
出版: (2016)

Novel Synthetic Oxazines Target NF-κB in Colon Cancer In Vitro and Inflammatory Bowel Disease In Vivo
由: Nirvanappa A.C., et al.
出版: (2018)

Inhibition of the JAK-STAT3 pathway by andrographolide enhances chemosensitivity of cancer cells to doxorubicin
由: Zhou, J., et al.
出版: (2011)

Targeting the STAT3 signaling pathway in cancer: Role of synthetic and natural inhibitors
由: Sikka, S., et al.
出版: (2014)

Potential role of signal transducer and activator of transcription (STAT)3 signaling pathway in inflammation, survival, proliferation and invasion of hepatocellular carcinoma
由: Subramaniam, A., et al.
出版: (2014)

Targeting STAT3 and oxidative phosphorylation in oncogene-addicted tumors
由: Lee M., et al.
出版: (2020)

Nanoparticles Targeting STATs in Cancer Therapy
由: Ashrafizadeh, M., et al.
出版: (2021)

Clinical and testing protocols for the analysis of epidermal growth factor receptor mutations in East Asian patients with non-small cell lung cancer: A combined clinical-molecular pathological approach
由: Salto-Tellez, M., et al.
出版: (2014)

Multiple roles of STAT3 in cardiovascular inflammatory responses
由: Lim, C.P., et al.
出版: (2014)

The IκB kinase inhibitor ACHP strongly attenuates TGFβ1-induced myofibroblast formation and collagen synthesis
由: Mia, M.M, et al.
出版: (2020)

Discovery of a small-molecule inhibitor of STAT3 by ligand-based pharmacophore screening
由: Leung, Ka-Ho, et al.
出版: (2016)

Inhibition of STAT3 dimerization and acetylation by garcinol suppresses the growth of human hepatocellular carcinoma in vitro and in vivo
由: Sethi, G., et al.
出版: (2014)

Diosgenin, a steroidal saponin, inhibits STAT3 signaling pathway leading to suppression of proliferation and chemosensitization of human hepatocellular carcinoma cells
由: Li, F., et al.
出版: (2011)

Stat3 contributes to keloid pathogenesis via promoting collagen production, cell proliferation and migration
由: Lim, C.P., et al.
出版: (2014)

STAT5 REGULATES HELPER T CELL LINEAGE COMMITMENT AND AUTOIMMUNITY
由: SHENG WANQIANG
出版: (2014)

Trisubstituted-imidazoles induce apoptosis in human breast cancer cells by targeting the oncogenic PI3K/Akt/mTOR signaling pathway
由: Mohan C.D., et al.
出版: (2018)

Phase 2 trial of linifanib (ABT-869) in patients with advanced non-small cell lung cancer
由: Tan, E.-H., et al.
出版: (2014)

Involvement of STAT5 in oncogenesis
由: Halim, C.E., et al.
出版: (2021)

Deregulation of a STAT3-interleukin 8 signaling pathway promotes human glioblastoma cell proliferation and invasiveness
由: De La Iglesia N., et al.
出版: (2018)

REGULATION OF AMPK ACTIVATION AND ITS ROLE IN CELL DEATH INDUCED BY GLUCOSE STARVATION IN LKB1-MUTANT HUMAN LUNG CANCER CELLS
由: REN YI
出版: (2019)

Low-capacitance StatCom with modular inductive filter
由: Farivar, Glen, et al.
出版: (2020)

Repression of Stat3 activity by activation of mitogen-activated protein kinase (MAPK)
由: Jain, N., et al.
出版: (2014)

Brassinin inhibits STAT3 signaling pathway through modulation of PIAS-3 and SOCS-3 expression and sensitizes human lung cancer xenograft in nude mice to paclitaxel
由: Lee, J.H, et al.
出版: (2020)

Targeting microtubules sensitizes drug resistant lung cancer cells to lysosomal pathway inhibitors
由: Chin, T.-M., et al.
出版: (2021)

γ-Tocotrienol is a novel inhibitor of constitutive and inducible STAT3 signalling pathway in human hepatocellular carcinoma: Potential role as an antiproliferative, pro-apoptotic and chemosensitizing agent
由: Rajendran, P., et al.
出版: (2014)